Drug Type Molecular glue |
Synonyms SPR 2015, SPR2015 |
Target |
Action inhibitors |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | China | 01 Oct 2025 | |
| Non-Small Cell Lung Cancer | Preclinical | China | 01 Oct 2025 | |
| Pancreatic Cancer | Preclinical | China | 01 Oct 2025 |





